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Abstract
Background: We have previously shown in vitro that UVA increases the adhesiveness of mouse B16-F1 melanoma
cells to endothelium.
We have also shown in vivo that UVA exposure of C57BL/6 mice, i.v. injected with B16-F1 cells, increases formation
of pulmonary colonies of melanoma. The aim of the present animal study was to confirm the previously observed
in vivo UVA effect and to determine whether in vitro UVA-exposure of melanoma cells, prior the i.v. injection, will
have an enhancing effect on the pulmonary colonization capacity of melanoma cells. As a second aim, UVA-
derived immunosuppression was determined.
Methods: Mice were i.v. injected with B16-F1 cells into the tail vein and then immediately exposed to UVA.
Alternatively, to study the effect of UVA-induced adhesiveness on the colonization capacity of B16-F1 melanoma,
cells were in vitro exposed prior to i.v. injection. Fourteen days after injection, lungs were collected and the
number of pulmonary nodules was determined under dissecting microscope. The UVA-derived immunosuppression
was measured by standard contact hypersensitivity assay.
Results and Discussion: Obtained results have confirmed that mice, i.v. injected with B16-F1 cells and thereafter
exposed to UVA, developed 4-times more of melanoma colonies in lungs as compared with the UVA non-exposed
group (p < 0.01). The in vitro exposure of melanoma cells prior to their injection into mice, led only to induction of
1.5-times more of pulmonary tumor nodules, being however a statistically non-significant change. The obtained
results postulate that the UVA-induced changes in the adhesive properties of melanoma cells do not alone account
for the 4-fold increase in the pulmonary tumor formation. Instead, it suggests that some systemic effect in a mouse
might be responsible for the increased metastasis formation. Indeed, UVA was found to induce moderate systemic
immunosuppression, which effect might contribute to the UVA-induced melanoma metastasis in mice lungs.
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Background
Ultraviolet-B radiation (UVB, 280-320 nm) is known for
its harmful DNA-damaging potential and carcinogenic
effects [1]. Ultraviolet-A radiation (UVA, 320-400 nm)
has also been shown to damage DNA [2-4], promote
carcinogenesis, and participate in the pathogenesis of
squamous cell carcinoma [4-6]. Some studies have
implicated UVA in the development of cutaneous
melanoma [7,8], whereas others found it as ineffective
[9]. In addition to UV’s carcinogenic effects, both UVB
and UVA radiation have been shown to induce local
and systemic immunosuppression [10-13]. UV-derived
immunosuppression has been identified as a risk factor
for skin cancer induction because it allows DNA-
damaged cells to survive and proliferate by escaping
from the surveillance of the immune system [14].
The possibility that UV radiation may affect melanoma
metastasis has not been addressed widely, although some
UV-derived biochemical responses, like above-mentioned
systemic immunosuppression or altered adhesion
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m e t a s t a s i s .W eh a v ep r e v i o u s l ys h o w ni nas m a l ls c a l e
pilot study that UVA causes an increase in the pulmon-
ary tumor formation in mice after intravenous inocula-
tion of mouse melanoma B16-F1 cells [16]. Pulmonary
colonization of the B16 cells after i.v. injection is a metas-
tasis-like event resembling the hematogenous metastasis
of melanoma and gives an indication of their metastatic
potential, as shown by Fidler [17,18]. We have also
demonstrated that UVA exposure causes the increase in
the adhesiveness melanoma cells to endothelium in vitro,
what is accompanied by changes in the expression of the
cell surface adhesion molecules [19]. Thus, we proposed
that the UVA-derived changes in the expression of adhe-
sion molecules could be, at least in part, responsible for
the in vivo observed increase of pulmonary tumor colo-
nies in mice.
The aim of the present animal study was to confirm
t h ep r e v i o u s l yo b s e r v e din vivo UVA-induced increase
in the melanoma tumor formation in mice lungs, and to
determine whether in vitro UVA-exposure of melanoma
cells will have similar enhancing effect on the pulmon-
ary colonization capacity of melanoma. The obtained
results postulate that in vivo irradiation of mice has
more significant effect on the pulmonary melanoma
metastases formation than in vitro irradiation of cells,
suggesting that some systemic effect in a mouse, rather
than a direct effect of the UVA on the melanoma cells,
might be responsible for the increased metastasis forma-
tion. One possible systemic effect could be the UV-
induced immunosuppression.
Methods
UVA radiation source and dosimetry
A facial tanner lamp, Philips HB 171/A (Philips, Ger-
many) with four Philips Cleo 15 W lamps, was used as a
radiation source. UVB radiation was filtered out with a 5
mm thick glass filter. The spectral irradiances were mea-
sured with a temperature stabilized Bentham DM150
(Bentham Instruments Ltd., Berkshire, England) double-
monochromator spectroradiometer at 0.5 nm intervals
from 250 nm to 400 nm as described previously [16,19].
The irradiances in both in vitro and in vivo irradiation
set-ups were measured at the same distance from the
lamp as in the actual UV-exposures. The attenuation
caused by the Petri dish lid and the culture medium was
taken into account in the in vitro experiments by mea-
suring the irradiance through dish cover and the culture
medium (data not shown). The irradiation spectra were
almost identical in both set-ups consisting of 99.99%
UVA and 0.01% UVB. The spectrum used in the in vivo
irradiations is shown in Figure 1a, in which UVA spec-
trum irradiating mice is indicated with a thick line after
filtration through a 5 mm glass plate.
The transmittance of mouse skin
T h et r a n s m i t t a n c eo fC 5 7 B L / 6m o u s es k i nw a sm e a -
sured ex vivo using the Bentham DM 150 spectroradi-
ometer (Bentham Instruments Ltd., Berkshire, England).
A Philips HP 3136 sun lamp (Philips, The Netherlands)
1,0E-04
1,0E-03
1,0E-02
1,0E-01
1,0E+00
1,0E+01
1,0E+02
1,0E+03
1,0E+04
260 280 300 320 340 360 380 400
Wavelength [nm]
S
p
e
c
t
r
a
l
 
i
r
r
a
d
i
a
n
c
e
 
[
m
W
/
m
²
n
m
]
UV-A UV-B
1,0E-06
1,0E-05
1,0E-04
1,0E-03
1,0E-02
1,0E-01
1,0E+00
1,0E+01
1,0E+02
1,0E+03
1,0E+04
280 300 320 340 360 380 400
Wavelength [nm]
S
p
e
c
t
r
a
l
 
i
r
r
a
d
i
a
n
c
e
 
[
m
W
/
m
²
n
m
]
UV-A UV-B c
0,00
0,02
0,04
0,06
0,08
0,10
0,12
0,14
0,16
0,18
0,20
280 300 320 340 360 380 400
Wavelength [nm]
T
r
a
n
s
m
i
t
t
a
n
c
e
 
 
b
a
Figure 1 The spectral irradiance and spectral transmittance of
UVA radiation. (a) The spectral irradiance of a Philips HB 171/A facial
tanner is indicated with a thin line. The irradiance with a glass plate
filter, cutting off the UVB portion, is indicated with thick line. (b) The
transmittance of three mice skins, measured ex vivo, is shown with 3
thin lines, respectively. The average transmittance is indicated by a
thick line. (c) The actual spectral irradiance transmitted through mice
skin (thick line) was determined by multiplying the measured spectral
irradiance of Philips facial solarium (thin line) with the average
transmittance (thick line in Figure 1b).
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is higher as compared to Philips HB 171/A facial solar-
ium used in the in vivo mice UVA irradiations, the
transmission through mice skin remains the same.
Hair on the mice abdomens was shaven off, after which
animals were euthanized and skin was removed. The
location and the size of shaved and removed skin were
identical to that used during in vivo UVA exposures.
The lamp spectrum was determined first, after which
spectral measurements were performed on three abdom-
inal skins. The spectral transmittance was calculated by
dividing the spectrum obtained through mouse skin by the
spectrum of the Philips HP 3136 sun lamp (Figure 1b).
The actual spectral irradiance transmitted through the
mouse skin during the UVA in vivo exposures was deter-
mined by multiplying the average spectrum of transmis-
sion (Figure 1b, thick line) with the spectrum of the used
Philips HB 171/A face solaria (Figure 1c, thin line). The
spectrum indicated with the thick line in Figure 1c depicts
the spectral irradiance transmitted through mouse skin
during the in vivo UVA irradiation experiments.
Cells
C57BL/6 mice-derived melanoma cell lines B16-F1 and
B16-F10 were purchased from National Cancer Institute,
Frederick Cancer Research & Development Center (Fre-
derick, MD, USA). Melanoma cell lines were grown in
RPMI-1640 and the cell culture media were supplemented
with 10% heat-inactivated FBS, penicillin (100 IU/ml),
streptomycin (100 μg/ml), and L-glutamine (4 mM). All
cell culture supplies were purchased from Gibco BRL,
Paisley, UK. Prior to injection melanoma cells were har-
vested with the EDTA cell stripper solution (140 mM
NaCl, 2.7 mM KCl, 8 mM Na2HPO4,0 . 5m ME D T A )t o
preserve surface adhesion molecules. Thereafter, the mela-
noma cells were washed once and 50.000 melanoma cells
were suspended in 0.2 ml of 0.9% NaCl for injection.
Animals
Female C57BL/6 (C57BL/6JOlaHSd) mice, Specific Patho-
gen Free (SPF) status according to Felasa Health Monitor-
ing Guidelines, were purchased from Harlan Laboratories,
The Netherlands, and housed in Viikki Laboratory Animal
Center, University of Helsinki, Finland. The ethical evalua-
tions of experiments were reviewed and approved by the
Institutional Animal Use and Care Committee of the Uni-
versity of Helsinki and The State Provincial Veterinarian
Office of Southern Finland. The care, welfare and use of
the animals were in accordance with national, institutional
and European guidelines. Mice were at 8-10 weeks of age
at the beginning of the experiments. There were no preg-
nant or lactating animals among the study subjects. Mice
were housed and arranged for the experiments to the
groups of five animals, with free access to water and food.
Prior to the experimental procedures mice were
anesthetized using a combination of a neuroleptanalgesic
drug Hypnorm (fentanyl citrate at 0.315 mg/ml and flua-
nisone at 10 mg/ml; Janssen Pharmaceutical, Tilburg,
The Netherlands), and a sedative Dormicum (midazolam
1 mg/ml, Roche, Basel, Switzerland). Mice were anesthe-
tized with intraperitoneal (i.p.) injection of a mixture of
Hypnorm-Dormicum diluted 1:1 vol/vol, and adminis-
tered 0.05-0.075 ml per animal.
Melanoma cell injection and in vivo UVA irradiation of
mice
All mice groups consisted of ten mice. The non-exposed
control mice were i.v. injected into the tail vein by the
suspension of 50.000 of B16-F1 (low-metastatic) or B16-
F10 (high-metastatic) cells in 0.2 ml of saline (Figure 2a),
as described previously [16]. Immediately after cell injec-
tion mice were sham-treated. In the UV-treatment
group, hair on the abdomens was shaven off to allow
UVA irradiation of skin, and mice were i.v injected into
the tail vein by the suspension of 50.000 of B16-F1 cells
in 0.2 ml of saline (Figure 2a). Immediately following the
B16-F1 cell injection, the abdominal side of mice was
exposed to a single UVA dose at 8 J/cm
2.S o m eo ft h e
animals were exposed to two more UVA doses (8 J/cm
2)
at 24 and 48 hours after the melanoma cell injection on
two consecutive post-injection days. Mice in all treat-
ment groups were terminated 14 days after melanoma
injection, lungs were removed and fixed in Bouin’ss o l u -
tion for 48 hours, after which the tumor colonization in
lungs was evaluated.
In vitro UVA irradiation of cells prior to their injection
The B16-F1 cells were exposed in the RPMI 1640 medium
to the single UVA dose of 8 J/cm
2, as described previously
[19]. The irradiation was performed at room temperature
in a dark room on a black support to avoid effects of
reflected radiation. The non-irradiated control B16-F1 and
B16-F10 cells were sham-treated by keeping at room tem-
perature in a dark room for the irradiation time. After
UVA exposure or sham treatment, the cells were washed
carefully twice with PBS, after which the suspension of
50.000 of B16-F1 or B16-F10 cells in 0.2 ml of saline was i.
v. injected into the tail vein of C57BL/6 mice (Figure 2b).
Mice were terminated 14 days after injection and the
lungs were removed and fixed in Bouin’s solution for 48
hours, after which the tumor colonization in lungs was
evaluated.
The evaluation of the pulmonary metastases
The quantitative evaluation of the pulmonary tumor
nodules was performed under dissecting microscope
(Wild Heerbrugg AG, Switzerland) by counting the
clearly visible and easily detectable tumors on the lung
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Page 3 of 8surface (Figure 3a), as described previously [16]. There-
after lungs were embedded in paraffin, cut using a
rotary microtome (Microm International GmbH, Wall-
dorf, Germany) in 5 μm-sections, stained with standard
hematoxyline-eosine method and examined for the pre-
sence of the invisible micrometastases in tissue parench-
yma under dissecting microscope (Figure 3b).
Statistical analysis of pulmonary tumor formation was
performed using non-parametric the Wilcoxon-Mann-
Whitney (rank sum) test between in vivo UVA-exposed
mice group and non-exposed mice group as well as
between the mice group treated either in vitro UVA-
exposed melanoma cells or the sham-treated cells. P
values were adjusted for multiple comparisons at signifi-
cance level of 0.05.
Contact Hypersensitivity (CHS) assay
In a pilot CHS-assay, each group consisted of ten mice.
In the repetition of the CHS assay, each group consisted
of 27 mice to obtain statistically more powerful analysis.
Experimental design showing time line and order of
procedures are shown in Figure 4. Mice were irradiated
on shaved abdomen with UVA at 8 J/cm
2 (group A).
Group A had its own irritant control mice (group C),
which was treated similarly as group A, but not sensi-
tized. The positive control group for CHS formation
(group B) was not UVA-exposed and it had its own
non-sensitized control group D. During UVA-exposure,
mice heads were covered with a loosen “cap”,m a d e
from black plastic electrical tape, to avoid the UV-
mediated alterations in the CHS response, when challen-
ging ears 10 days later. This protective cap did not
interact with the ear skin, thus causing any potential
irritation on the skin, or did not prevent normal respira-
tion of the animals.
Three days after the UVA/sham treatment, 2% oxazo-
lone (4-ethoxymethylene-2-phenyl-2-oxazolin-5-one, dis-
solved and diluted in acetone) (Sigma Chemical Co., St.
Louis, MO, USA), was applied as a sensitizer (100 μl,
corresponding 2 mg of oxazolone) to the shaved back of
mice that received UVA radiation (group A) as well as
of the CHS positive control mice (group B) under
anesthesia. The sensitization procedure was not per-
formed to the irritant controls groups C and D.
The challenging dose of the sensitizer (10 μl, corre-
sponding 200 μg of oxazolone) was applied to both ear
pinna 7 days after sensitization for all groups. The thick-
ness of the ears was measured before application and 24
h later with Pocket Thickness Gage No. 7309 (Mitutoyo
Corp., Japan). Thickness of the ears was measured by
two persons, both measuring their own mice, and the
same number of mice from all the treatment groups.
The change of the ear thickness was calculated from
both ears by subtracting the original thickness from the
challenged ear thickness and taking the average from
these two values. Finally, the UVA induced suppression
s was calculated according to the formula (1) [20]. A, B,
C, and D are the average swelling figures for the respec-
tive animal groups 24 hours after challenge as follows:
s=1− [(A − C)/(B − D)] (1)
Statistical significance of UVA immunosuppression
was analyzed using the analysis of covariance. The aver-
age change in the ear thickness was first explained by
the group (A, B, C, D) and the average original thickness
as covariate. The average change was analyzed further
by including the measurer in the model. A priori, the
average difference in the effect of B-D was assumed to
be larger than that of A-C based on results obtained
from a pilot CHS assay. The average difference between
Mice exposure with UVA 8 J/cm2
or 3x8 J/cm2
d0 d1 d2 …d14
The in vivo exposure of mice 
melanoma cell
injection
Harvesting lungs
a
B16-F1 cell exposure
with UVA 8 J/cm2
d0 …d14
melanoma cell
injection
The in vitro exposure of melanoma cells 
Harvesting lungs
b
Figure 2 Time-line of the animal study. (a) Mice were injected with B16-F1 cells into the tail vein and immediately after injection exposed in
vivo to one, or three consecutive, dose of UVA. (b) B16-F1 cells were in vitro exposed to the single dose of 8 J/cm
2 UVA before injection into
the tail vein. In the both experimental set-ups, fourteen days after melanoma cell injection mice lungs were removed, fixed, and melanoma
nodules were counted on the lung surface.
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sided significance level of 0.05.
Results
The majority of UVA was absorbed in the mouse skin
The transmittance of the UVA wavelengths through
mice skin (n = 3) varied from 5% to 15% as shown in
Figure 1b, indicating that the majority of the UVA
radiation, approximately 90%, was absorbed in the
mouse skin. The actual spectral irradiance transmitted
through mice skin during the in vivo irradiation is
shown with the thick line in Figure 1c.
In vivo UVA irradiation of mouse increased remarkably
the pulmonary metastasis formation
In vivo UVA irradiation of mice that were injected with
low-metastatic B16-F1 melanoma prior to the exposure
caused a remarkable increase in the number of pulmonary
b Examples of H&E cross sections a Examples of lungs
Figure 3 Representative examples of the lungs and of the lung cross sections after UVA radiation and B16-F1 cell injection. (a)
Metastatic nodules, which were clearly visible on the lung surface, were counted under dissecting microscope (magnification of the objective
6×). (b) Lung cross sections (5 μm) were stained with H&E to determine the lung tissue morphology and the appearance of tumors
(magnification of the objective 10×).
1st UVA dose
on abdomen
3rd UVA dose
on abdomen
Sensitizing
back with
oxazolone
Measuring the 
original ear
thickness, then
Challenging ears
with oxazolone
Measuring
change in ear
thickness
2nd UVA dose
on abdomen
Day 13 Day 1 Day 2 Day 12 Day 0 Day 5
Single UVA 
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on abdomen
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Measuring the 
original ear
thickness, then
Challenging ears
with oxazolone
Measuring
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thickness
UVA 
3x8 J/cm2
UVA 
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Figure 4 Time-line of the CHS assay showing the order of procedures. Mice were irradiated with a single dose of UVA or consecutive doses
of UVA in three days. Three days later from the latest UVA dose, mice were sensitized to the shaved back with oxazolone. Mice were challenged
with oxazolone to both ear pinna 7 days after sensitization. The thickness of the ears, i.e. ear swelling, was measured 24 hours after challenge.
Pastila et al. Cancer Cell International 2011, 11:16
http://www.cancerci.com/content/11/1/16
Page 5 of 8metastases. Animals exposed to a single dose of UVA
(Table 1, group 1c) developed 4-times more metastases as
compared to the non-irradiated mice injected with the
B16-F1 cells (Table 1, group 1a). This difference was sta-
tistically significant (p < 0.01).
The effect of three repetitive UVA exposures had
weaker effect on the metastatic potential of B16-F1 cells
than the single UVA exposure. Although there was a
2.5-fold increase in the metastases formation (Table 1,
group 1d) as compared to the non-exposed controls
(Table 1, group 1a), it was statistically non-significant.
However, the number of metastases remained high on
the lung surface after three doses of UVA and reached
the same level than the positive controls animals,
injected with high-metastatic B16-F10 cells (Group 1b,
Table 1).
In vitro irradiation of B16-F1 cells had a minor effect on
the metastatic potential
In vitro UVA irradiation of B16-F1 cells prior to the cell
injection caused a small, only 1.5-fold increase in the
number of pulmonary metastases (Table 1, group 2c) as
compared to animals that were injected with the non-
irradiated B16-F1 cells (Table 1, group 2a). Although
this change was ca. 50% increase in tumor formation, it
was not statistically significant.
UVA radiation caused a moderate immunosuppression
determined by CHS
The pilot CHS assay (n = 10 mice/group) showed a
non-significant 13.8% increase in immunosuppression in
UVA irradiated mice (data not shown). Irradiation of
mice with three consecutive UVA doses neither induced
decline nor increase in the CHS effect (data not shown).
The repetition of CHS assay (n = 27 mice/group)
showed an increase in immunosuppression by 16.6%
(p = 0.0265, one-sided) after the single dose of UVA. In
the positive control group for CHS formation (group B,
Figure 5), the mean ear swelling was 27.5 × 10
-2mm
after subtracting the background (group D). In the
UVA-irradiated mouse group (group A), mean ear swel-
ling declined to 22.9 × 10
-2mm, after background
subtraction (group C). The average ear thickness change
of each mouse was calculated using measures for each
ear thickness pre- and post-challenge. Two persons
measured thickness of the ears and the both measurers
found the same trend in the ear swelling figures, but dif-
ferences existed between the measurers.
Discussion
In this study we confirmed our previous finding that
UVA increases the pulmonary colonization capacity of
mouse melanoma [16] and demonstrated that a single
UVA exposure of mice with i.v. injected B16-F1 mela-
noma cells caused statistically significant, 4-fold increase
in the metastasis in terms of pulmonary colonization.
Exposing the B16-F1 i.v. injected animals to UVA radia-
tion on three consecutive days, the number of pulmonary
metastases remained high, but the result was statistically
non-significant as compared to the non-irradiated con-
trols. Nevertheless, the tumor formation capacity was
comparable with the number of pulmonary metastases
formed by highly-metastatic B16-F10 cells.
The transmittance of the mouse skin was measured to
determine how much the UVA radiation attenuates when
interacting with the skin tissue, and whether UVA reaches
the dermis and thus, presumably the circulating melanoma
cells in the capillary network. In the human skin UVA
radiation is able to penetrate to the upper dermis. Mouse
epidermis is approximately 10 μm and for dermis 250 μm
[21], being remarkably thinner as compared to human
skin (1-4 mm). In this study, approximately 90% of the
used UVA wavelengths were absorbed in the skin and
~10% was transmitted through it. Thus, UVA had a possi-
bility to affect the epidermal cells, such as keratinocytes
and mast cells, which are known to be rich source of
immunologically active compounds [11,12], but also affect
the cells in the dermis.
Previously we have hypothesized that the UVA-
induced changes in the melanoma adhesiveness, and in
the adhesion molecule expression in vitro [19], might be
factors that could be responsible for the increased meta-
static potential in vivo. To validate this hypothesis in the
current study, the low-metastatic B16-F1 cells were
Table 1 The quantitative evaluation of the pulmonary melanoma nodules on the lung surface
Treatment
1 Tumors Treatment
2 Tumors
In vivo Number per ten mice Median In vitro Number per ten mice Median
1a: B16-F1 27 2 2a: B16-F1 22 2
1b: B16-F10 70 4.5 2b: B16-F10 82 5
1c: B16-F1 + UVA 117* 7.5 2c: B16-F1 + UVA 34 2
1d: B16-F1 +
3 × UVA
72 4 - - -
1 C57BL/6 mice (n = 10) were in vivo irradiated after i.v. melanoma cell injection into the tail vein. *p < 0.01.
2 B16-F1 melanoma cells were in vitro irradiated before their i.v. injection into the tail vein of C57BL/6 mice (n = 10).
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2
prior to the cell injection. This treatment increased the
metastatic capacity of melanoma cells only by 1.5-fold,
being a statistically non-significant change. The apopto-
sis or necrosis of the cells after in vitro UVA radiation
cannot explain the overall lower metastatic potential of
the B16-F1 melanoma, since either the used UVA dose
[19], or RPMI media during irradiations (unpublished
finding), were not found to cause any adverse cellular
effects or cell death. Furthermore, the in vitro or in vivo
irradiation modality did not seem to cause any differ-
ences in the location or morphology of the metastases:
histological evaluation of haematoxylin-eosin stained tis-
sue revealed that the vast majority of the tumors were
visible on the lung surface and metastases were rarely
seen deep inside the lung parenchyma regardless the
used UV delivery method. This is also in accordance
with our pilot histology analysis [16], which showed that
the majority of the metastases were seen on the lung
surface.
This result obtained here suggests that other mechanism
(s), than the UVA-induced endothelial adhesiveness of
melanoma cells, might play a role in the UVA-induced
increase of the pulmonary metastasis formation. One such
mechanism could be the UV-induced systemic immuno-
suppression that might help in the progression of metasta-
sis by impairing the melanoma cell rejection in the UV-
exposed mice, in a similar way how the drug-mediated
immunosuppression has been shown to enhance the skin
tumor invasion in the patients undergoing organ trans-
plantation [22,23]. UV-derived immunosuppression was
first associated with UVB radiation, and is utilized widely
in the UVB-phototherapy treatments for a variety of differ-
ent dermatoses [24,25].
In our current study the UVA-induced systemic immu-
nosuppression was measured by the contact hypersensi-
tivity assay that has been shown to be an informative and
useful approach to determine the UV-induced immune
responses in mice [26]. Both our CHS assays showed the
same trend; the single UVA dose at 8 J/cm
2 caused a
moderate increase in systemic immunosuppression as
compared to the non-exposed control animals. This find-
ing was in accordance with Byrne et al., who has also
shown that UVA irradiation suppressed the systemic
contact hypersensitivity in C57BL/6 mice [10]. They have
also shown that in contrast to primary UVA-induced
immunosuppression, further UVA irradiation of C57BL/
6 mice enhanced the secondary immune responses. Our
current result agrees with Byrne’s finding since the
immunosuppression of systemic contact hypersensitivity
was not present anymore when the three UVA doses
were applied in our pilot CHS study. In our model, the
consecutive UVA exposures might have had an anti-
immunosuppressive effect offering an explanation for the
observation that three exposures delivered on the three
consecutive days, had weaker pro-metastatic effect than
the single dose in terms of pulmonary metastases forma-
tion (data-not shown).
The immunosuppression data presented in this study do
not, however, show whether UVA is directly involved in
the decline of the cellular immunity against tumor cells,
and it needs to be confirmed in the future studies. This
data only demonstrates that UVA enables the melanoma
metastasis in mice, possibly in the similar manner that
UV-mediated immunosuppression enables the trans-
planted tumors to grow in the UV-treated mice, in which
tumor growth was only apparent, if the recipient mice
were first UV exposed before cell injection, whereas the
non-exposed recipients were able to reject the tumor cells
[27,28].
Conclusion
UVA irradiation is capable to enhance the pulmonary
metastasis in a mouse model, but our results suggest that
some UVA-induced systemic effect(s) in mice plays more
prominent role in the enhanced melanoma metastasis
than the direct UVA-induced increase in adhesiveness of
melanoma cells. UVA was found to induce moderate sys-
temic immunosuppression, which effect might contribute
to the UVA-induced melanoma metastasis. The used
UVA dose of 8 J/cm
2 roughly corresponds to the UVA
dose received approximately within 1 hour on a sunny
summer day in Finland, thus being physiologically rele-
vant also for humans. These results presented in this
study suggest that, if occurring also in humans, exposure
12.78
11.65
40.26
34.58
0 5 10 15 20 25 30 35 40 45 50
Group D: Irritant
control for B
Group C: Irritant
control for A
Group B: Positive
control for CHS
formation, no UVA
Group A: UVA-
irradiated mice
Ear thickness 10-2 mm
Figure 5 UVA-derived moderate immunosuppression after
single dose of UVA. Changes in the ear thickness as a measure of
immunosuppression are shown in mice irradiated with a single
dose of UVA (group A) as compared with the non-irradiated,
positive control group for CHS formation (group B). Groups C and D
are the irritant (non-sensitized) controls for UVA treated mice (A),
and for non-irradiated mice (B), respectively. Error bars depict
standard deviations.
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